← Clinical Evidence

SRC-d7de1daef925 Martignon C 2021

Evidence source and scope

The key role of physical activity against the neuromuscular deterioration in patients with Parkinson's disease.

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1111/apha.13630

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Martignon C, Ruzzante F, Giuriato G, Laginestra FG, Pedrinolla A, Di Vico IA, et al. The key role of physical activity against the neuromuscular deterioration in patients with Parkinson's disease. Acta Physiol (Oxf). 2021;231(4):e13630. DOI 10.1111/apha.13630

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — strength

STR-51-01

Limitations: Only current scoped checks; archived captures not authenticated against live originals.

Parkinson’s disease strength

Parkinson’s disease strength component — Active-PD strength and rapid neural impairment

The abstract confirms 10 active PD/10 matched controls, similar MVC/PCSA and reduced voluntary activation/early RTD. The report appropriately avoids attributing preservation causally to activity.

Source locator: Primary abstract

Limitations: AI-assisted source comparison; no raw-data verification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide